Prot #B-VEC-EX-02: Open Label Treatment of Beremagene Geperpavec (B-VEC)

Project: Research project

Project Details

StatusActive
Effective start/end date8/12/218/12/24

Funding

  • Krystal Biotech, Inc. (Prot #B-VEC-EX-02)